Best Income Stocks To Buy Right Now


Another day, another dollar for the S&P 500 Index (SNPINDEX: ^GSPC  ) . Thursday’s 0.4% advance marks the fifth straight day that the index has posted gains, this time, on the heels of data from the Labor Department showing a continued slide in applications for unemployment benefits. Overall, today was just another good day to own equities. But there are always a few bad apples, so without further ado, let’s take a brief look at the cause of the rot in these three S&P sluggards. 


Safeway (NYSE: SWY  ) was no safe haven for its stockholders today, slipping 13.9% on results that reveal several things. The first and most obvious is that Safeway’s numbers aren’t blowing anyone away; comparable store sales were barely up, while margins took a hit. The second — and arguably more disturbing — thing we can glean from results is the fact that the grocer took a massive tax break in a relatively weak quarter, raising eyebrows about how desperately the company panders to financial appearance vs. well, you know, reality. 

Best Income Stocks To Buy Right Now: California Republic Bancorp (CRPB)


California Republic Bank (the Bank) provides an integrated banking solution to its customers. The Company provides a range of products and services, such as deposit and cash management, loans and private banking. The deposit and cash management include real time, online Internet banking, business analyzed checking, IOLTA accounts, NOW Accounts, nationwide network of cash vault centers, remote Deposit capture, fully automated domestic and international wire transfers, lockbox processing services, free worldwide automated teller machines (ATM) and debit cards, credit cards and purchase card services, customized merchant banking services, fraud prevention products including positive-pay, secure online applications, including token device with internal control access, and contractor Retention Escrow Accounts.


The loan services include unsecured lines of credit, secured revolving lines of credit, working capital loans, equipment financing, asset based credit lines, commercial owner occupied real estate loans, investor real estate loans and construction loans. Its private banking includes full array of private banking loans and lines of credit, Bill pay services, and stock secured credit lines and loans.

The Bank provides banking services to commercial entities, their owners, high net-worth individuals and active investors. It provides commercial banking, lending services, deposit services, contractor retention escrow accounts, cash management, remote deposit capture, private banking, online banking and auto finance.


The commercial banking includes online banking services, cash management products and services, remote deposit capture, contractor retention escrow accounts, domestic and international wire transfers, checking accounts, NOW accounts, money market accounts (MMA), savings accounts, certificates of deposit (CDs), corporate credit card, analyzed accounts and IOLTA accounts. The Bank offer lines of credit to provide working capital for day-to-day operations, term loan! s for equipment, and commercial real estate loans for facilities and for investment portfolio.


The cash management includes Account Analysis, Master Agreement Accounts, Account Reconciliation, Remote Deposit Capture (RDC), Online Cash Management, Automated Clearing House (ACH) Services, Bill Pay, Lockbox Services, Positive Pay, Zero Balancing Accounts, Merchant Card, Reverse Wires, Statements on CD Rom, Corporate Credit Card, Courier Service and Bank by Mail.

Advisors’ Opinion:

  • [By CRWE]

    Today, CRPB remains (0.00%) +0.000 at $19.00 thus far (ref. google finance Delayed:   11:35AM EDT July 29, 2013).

    California Republic Bancorp previously reported its results for the second-quarter 2013, reporting quarterly net income of $2.8 million, record net interest margin of 6.41%, record assets of $737.1 million and record deposits of $669.7 million.


    CEO Jon Wilcox stated, “In the second-quarter we not only experienced strong deposit and loan growth, but also continued to invest in our people and infrastructure both in California as well as nationally, while increasing our bottom line and maintaining solid credit quality.”

Best Income Stocks To Buy Right Now: Targacept Inc.(TRGT)

Targacept, Inc., a biopharmaceutical company, engages in the discovery, design, and development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of diseases and disorders of the nervous system. Its products include TC-5214, a nicotinic channel modulator, which is in Phase III clinical trials as an adjunct treatment for depressive disorder; and in Phase IIb clinical trial for switch monotherapy in patients with depressive disorder. The company?s small molecule products include TC-5619, which is under two separate Phase II clinical trials to treat negative symptoms and cognitive dysfunction in schizophrenia, inattentive-predominant attention deficit/hyperactivity disorder, and Alzheimer?s disease; AZD3480, a product under Phase IIb clinical trials for the treatment of mild to moderate Alzheimer?s disease; AZD1446 for treatment of Alzheimer?s disease; TC-6987 under Phase II clinical trials to treat asthma and type 2 diabetes; and TC-6499 for the treatm ent for gastrointestinal disorders. It has a collaborative research and license agreement with AstraZeneca AB for the development and commercialization of AZD3480, TC-5214, and TC-5619; and a product development and commercialization agreement with SmithKline Beecham Corporation and Glaxo Group Limited to discover, develop, and market product candidates that selectively target specified NNR subtypes in specified therapeutic focus areas. Targacept, Inc. was founded in 1997 and is based in Winston-Salem, North Carolina.


Advisors’ Opinion:

  • [By DailyFinance Staff]

    Investors took a wait-and-see attitude Tuesday, but airline stocks lost altitude. The market is in a holding pattern until 2 p.m. Wednesday, when the Fed reveals details of this week’s FOMC policy meetings, and whether it’s ready to begin cutting back on its main economic stimulus program. If it does begin to taper, the next debate will begin immediately: Is that good or bad for investors? On Wall Street today, the Dow Jones industrial average (^DJI) edged down 9 points, the Nasdaq composite (^IXIC) fell nearly 6, and the Standard & Poor’s 500 index (^GPSC) lost 5 points. The Dow’s gainers were led by a pair of companies hiking their dividends. 3M (MMM), which makes everything from Post-It notes to medical equipment, rose 3 percent after increasing its payout by 35 percent. And Boeing (BA) rose 1 percent. It boosted the dividend by 50 percent and announced a big stock buyback. The other big blue chip winner was Visa (V), which gained another 2.5 percent. Its stock is now up 43 percent from a year ago. On the downside, Verizon (VZ), IBM (IBM), McDonald’s (MCD) and Microsoft (MSFT) all lost about one percent. Microsoft says it will not name a new CEO until next year. And airline stocks were broadly lower. United (UAL) and Delta (DAL) both fell 3 percent. American Airlines (AAL), which completed its merger with U.S. Airways last week, fell 2 percent. And Southwest (V) also lost 2 percent. Brokerage recommendations gave a boost to several issues. Data storage companies Seagate (STX), up 3 percent, and Western Digital (WDC), up 2.5 percent, following JP Morgan upgrades. And iRobot (IRBT) surged 17 percent after Raymond James gave it a ‘strong buy.’ Shares of Facebook (FB) rose 2 percent, hitting an all-time high. The social media giant is rolling out new video ads this week. That’s expected to boost revenue. The question is, will it alienate users? On the downside, Targacept (TRGT) lost more than a third of its value. A clinical trial of its schizophreni

  • [By Lauren Pollock]

    Targacept Inc.’s(TRGT) investigational secondary treatment for schizophrenia didn’t show significant improvement in negative symptoms or cognitive function in a Phase 2b trial after 24 weeks. The biopharmaceutical company said it wouldn’t pursue further development of the therapy for the mental illness or for Alzheimer’s Disease. Shares fell 31% to $4.09 premarket.

Best Income Stocks To Buy Right Now: Special Opportunities Fund Inc.(SPE)

Special Opportunities Fund, Inc. is a close-ended fund of funds launched and managed by Brooklyn Capital Management LLC. It invests in close-ended funds investing in public equity and fixed income markets. The fund employs a combination of value, opportunistic and special situations strategies to make its investments. It benchmarks the performance of its portfolio against the S&P 500 Index. The fund was previously known as Insured Municipal Income Fund, Inc. Special Opportunities Fund, Inc. was formed on February 18, 1993 and is domiciled in the United States.


Advisors’ Opinion:

  • [By Whopper Investments]

    For example, his Special Opportunity Fund (SPE) needed more capital to effectively implement its activist strategy after he took over. Unfortunately, most of the ways to raise capital are expensive and seriously dilute shareholder value. For example, a common stock offering, the most common way a closed end fund would raise capital, has to be priced at a discount and an investment bank needs to be paid to organize and sell it. Obviously, paying to issue shares at a discount is a disaster for long term shareholder value, so he instead pursued a rights offering for convertible preferred stock, which allowed the company to raise money without the expense of an investment bank while allowing shareholders the opportunity to increase their holdings in the fund without paying a commission. From the prospectus,

Best Income Stocks To Buy Right Now: LVMH Moet Hennessy Louis Vuitton SA (MC)


LVMH Moet Hennessy Louis Vuitton SA, (LVMH), is a France-based luxury goods company. It owns a portfolio of luxury brands and its business activities are divided into five segments: Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, and Selective Retailing. The activities of the wines and spirits sector include the Champagne and Wines branch, and the Cognac and Spirits branch. The Fashion and Leather Goods group includes Louis Vuitton, Kenzo and Rossimoda among others. LVMH is present in the perfume and cosmetics sector through the French Houses Christian Dior and other brands. Watches and Jewelry sells such products as TAG Heuer, Zenith, Dior Watches, Chaumet and Fred, among others. Selective Retailing businesses operate in two segments: travel retail and the seleLVMH ctive retail concepts represented by Sephora and Le Bon Marche. In September 2013, the Company acquired majority stake in Nicholas Kirkwood, a British shoe designer compa ny. Advisors’ Opinion:

  • [By Sarah Jones]

    LVMH Moet Hennessy Louis Vuitton (MC) SA rose 2.1 percent to 123.30 euros after Goldman Sachs Group Inc. added the luxury- goods maker to its conviction buy list, saying the stock’s underperformance presented an opportunity to invest. The shares fell 8 percent from April 15 through yesterday after the company reported the slowest growth in sales of fashion and leather products since 2009.

Best Income Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of H untington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.


Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Equities Trading UP
    Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

  • [By Jake L’Ecuyer]

    Equities Trading UP
    Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up 53.25 percent to $101.47 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

  • [By Markus Aarnio]

    2. Alnylam Pharmaceuticals (ALNY), a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference [RNAi].

Best Income Stocks To Buy Right Now: Transocean Inc.(RIG)

Transocean Ltd. provides offshore contract drilling services for oil and gas wells worldwide. It offers deepwater and harsh environment drilling, oil and gas drilling management, and drilling engineering and drilling project management services. The company also offers well and logistics services. In addition, it engages in oil and gas exploration, development, and production activities primarily in the United States offshore Louisiana and Texas, and in the United Kingdom sector of the North Sea. As of February 10, 2011, the company owned, had partial ownership interests in, and operated 138 mobile offshore drilling units, including 47 high-specification floaters, 25 midwater floaters, 9 high-specification jackups, 54 standard jackups, and 3 other rigs, as well as 1 ultra-deepwater floater and 3 high-specification jackups under construction. Transocean Ltd. was founded in 1953 and is based in Zug, Switzerland.


Advisors’ Opinion:

  • [By Dan Burrows]

    To get a sense of what’s out there among high-yield dividend stocks, here are the top 10 S&P 500 dividend stocks for March. (Note: All dividend yields are as of 10 a.m., Mar. 11.)

    #10: Transocean (RIG)

    RIG Dividend Yield: 5.29%

  • [By Ben Levisohn]

    Companies that could benefit from a pickup in capital spending include Akamai Technologies (AKAM) and priceline.com (PCLN), which have the highest sensitivity to “non-residential fixed investment in Intellectual Property Products,” Frontier Communications (FTR) and Lam Research (LRCX), which have the highest sales sensitivity to non-residential fixed investment in Equipment,” and Transocean (RIG), which is among the companies with a high exposure to “non-residential fixed investment in Structures.”

Best Income Stocks To Buy Right Now: Beeston Enterprises Ltd (BESE)


Beeston Enterprises Ltd, incorporated on July 12, 1999, is an exploration stage company that engages principally in the acquisition, exploration, and development of resource properties. The Company acquired a 100% interest in 19 mineral claims, comprising over 9,200 hectares, known as the Ruth Lake Property, located 25 kilometers from Lac La Hache, British Columbia, Canada. As of December 31, 2012, the Company owns five mineral claims in this area, all of which are in good standing.

The Company’s British Columbia, Canada property is located in the Quesnel Trough. This belt is known for hosting skarn and porphyry copper and copper-gold deposits. The property is being investigated by the Company in Arizona, United States of America is also in a well known gold/silver mining area.


Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks Beeston Enterprises Ltd (OTCMKTS: BESE) and HD Retail Solutions Inc (OTCMKTS: HDRE) surged 33.33% and 11.54%, respectively, on Black Friday while Frontier Beverage Company Inc (OTCMKTS: FBEC) sank 18.18%. And while Black Friday might be the most important shopping day of the year for retailers, its probably not a day that sees a lot of action from investors and traders still digesting their Thanksgiving meals (or busy looking for deals at their favorite retailers). So what direction will these three small cap stocks do for investors and traders this week? Here is a closer look to help you decide:

Best Income Stocks To Buy Right Now: Ikanos Communications Inc.(IKAN)


Ikanos Communications, Inc. provides broadband semiconductor and software products for the digital home. The company develops and markets end-to-end products for the last mile and the digital home, which enable carriers to offer triple play services, including voice, video, and data. It offers broadband digital subscriber line (DSL) products, such as high-density and low-power asymmetric DSL, and very-high-bit rate DSL products; communications processors that support various wide area network topologies, including passive optical network, DSL, wireless broadband, and Ethernet; and other products for access infrastructure and customer premises equipment (CPE) to network equipment manufacturers and telecommunications service providers. The company?s products comprise digital subscriber line access multiplexers, optical network terminals, concentrators, modems, voice over Internet protocol terminal adapters, integrated access devices, and residential gateways. It primarily s erves original design manufacturers, contract manufacturers, network equipment manufacturers, and original equipment manufacturers through direct sales and third-party sales representatives worldwide. The company was formerly known as Velocity Communications and changed its name to Ikanos Communications, Inc. in December 2000. Ikanos Communications, Inc. was incorporated in 1999 and is headquartered in Fremont, California.


Advisors’ Opinion:

  • [By Victor Selva]

    On Dec.24, Mario Gabelli, the Chairman and Chief Executive Officer of GAMCO Investors, Inc. added Communications Systems Inc. (JCS) at an average price of $11.05 and currently holds 330,172 shares of the stock. It was the 5th time he added the stock during this year, which makes me feel that he is betting in favor of a positive future for the consumption of network capacity.
    Recommendations of the Board
    Communications Systems is engaged in the manufacture and sale of modular connecting and wiring devices for voice and data communications, digital subscriber line filters, and structured wiring systems, and through its Transition Networks business unit in the manufacture of media and rate conversion products for telecommunications networks.
    Few months ago the firm announced a series of actions to increase revenues and improve profitability. The first change was to operate as a holding company, monitoring and supporting all the business units: Suttle, Transition Ne tworks (TN) unit and JDL Technologies. With this “new format”, each unit will operate with a high degree of autonomy. This will result in the reduction of labor costs, the emphasizing of accountability in the units as well as better recognition of performance. “While difficult decisions for the Board, we believe the changes we have taken to restructure our parent company as a holding company and to focus on individual business unit performance is in the best interest of our shareholders and will increase shareholder value” said Curtis A. Sampson, the Company’s Board Chair and Interim CEO. Furthermore, strategic investments in the TN unit such as marketing, sales and product development will boost revenues in the future.
    Severe Warning Signs
    Not all are good news, we found three severe warning signs issued by GuruFocus: Piotroski F-Score of 2 is low, which usually implies poor business operation; revenue has been in decline over the past 3 years and operating margi n has been in 5-year

Best Income Stocks To Buy Right Now: DCT Industrial Trust Inc (DCT)


DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc. is the sole general partner. The Company owns properties through its operating partnership and its subsidiaries. As of December 31, 2011, DCT owned approximately 90% of the outstanding equity interests in its operating partnership. In March 2012, DCT acquired a 32.6 acre land parcel in Romeoville, within the southern I-55 industrial submarket of Chicago. In May 2012, the Company acquired two Class A industrial buildings to taling 98,000 square feet in Houston, known as DCT Claymoore Center. Located in the Northwest submarket of Houston, DCT Claymoore Center encompasses a bulk and light industrial facility and is 95.8%-occupied.


During the year ended December 31, 2011, the Company acquired 24 buildings comprising 2.8 million square feet and controlling ownership interests in three buildings totaling 0.4 million square feet. In 2011, the Company sold 16 operating properties totaling approximately 2.7 million square feet to third-parties. As of December 31, 2011, the Company’s consolidated operating properties had leases with approximately 900 customers with no single customer accounting for more than 1.7% of the total annualized base rents of its properties. As of December 31, 2011, the Company owned interests in, managed or had under development approximately 75.5 million square feet of properties leased to approximately 900 customers, including 58.1 million square feet comprisi ng 408 consolidated properties owned in its operating portfo! lio, which were 90.6% occupied; 0.2 million square feet comprising one consolidated property under redevelopment, and 17.2 million square feet comprising 52 unconsolidated properties, which were 86.3% occupied and one managed-only property operated on behalf of five institutional capital management partners. As of December 31, 2011, its total consolidated portfolio consisted of 409 properties with an average size of 142,000 square feet and an average age of 20.2 years.


Advisors’ Opinion:

  • [By Brad Thomas]

    Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)

    Source: Chambers Street: More Liquidity Magic On The Way In REIT-Dom

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

Best Income Stocks To Buy Right Now: Aegerion Pharmaceuticals Inc.(AEGR)

Aegerion Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of novel therapeutics to treat debilitating and fatal rare diseases. The company focuses on therapeutics to treat severe inherited lipid disorders. Lipids are naturally occurring molecules, such as cholesterol and triglycerides that are transported in the blood. Its lead product, lomitapide has completed pivotal Phase III clinical trial to treat patients with a rare inherited lipid disorder called homozygous familial hypercholesterolemia, or HoFH. The company also plans to develop lomitapide for the treatment of adult patients with a severe genetic form of hypertriglyceridemia called familial chylomicronemia. Aegerion Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.

Advisors’ Opinion:

  • [By Ernie Tremblay, Biosciences Specialist, Money Morning | January 17, 2014 · ]

    Back in August 2012, I noticed that a tiny biotech called Aegerion Pharmaceuticals (Nasdaq: AEGR) was about to present lomitapide, the one and only drug in its pipeline, to an FDA AdCom (Advisory Committee). AdComs are catalysts, key points in the drug development regulatory process that can make a company’s stock soar – or nosedive.

  • [By Brian Orelli]

    According to an abstract posted at Forbes, Amgen’s PCSK9 inhibitor was able to help some patients with a rare genetic disease that causes extremely high levels of cholesterol. For some patients, the drug, dubbed AMG 145, seems to work as well as Aegerion’s (NASDAQ: AEGR  ) Juxtapid or Kynamro from Isis Pharmaceuticals (NASDAQ: ISIS  ) and Sanofi, without the side effects. In addition to taking some sales from Juxtapid and Kynamro, AMG145 looks poised to treat patients with less severe cholesterol problems given the clean side effect profile.

  • [By David Williamson]

    It looks like the CHMP, Europe’s version of the FDA advisory committee, didn’t want the month to end without two big positive opinions, giving investors a nice little present heading into the weekend. Celgene’s (NASDAQ: CELG  ) relapsed and refractory multiple myeloma drug pomalidomide, and Aegerion’s (NASDAQ: AEGR  ) HoFH drug Juxtapid, are now likely to be approved in the EU.